Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578


News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

09/15/2012 | 08:11am US/Eastern

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on SANOFI
11:00a GENZYME : CSM Appoints Michael Morse as Vice President of Finance
07:43a SANOFI : MILITARY $25,181 Federal Contract Awarded to Sanofi Pasteur
03:07a GENZYME : CSM Appoints Michael Morse as Vice President of Finance
07/06 HARVARD APPARATUS REGENERATIVE TECH : OLOGY, INC. : Change in Directors or Princ..
07/06 Sarepta Therapeutics Taps Henri Termeer as Advisor to the Company
07/03 SANOFI : S new basal insulin lantus xr, known as toujeo in the u.s. and europe, ..
07/03 ZHEJIANG HISUN PHARMACEUTICAL : Pharma Enters into Memorandum of Understanding (..
07/03DJSANOFI : Gets Approval from Japan for Toujeo Diabetes Drug
07/03 SANOFI : New Basal Insulin Lantus® XR, Known as Toujeo® in the U.S. and Europe, ..
07/02 Ergomed Appoints Andrew Mackie As Executive Director
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials